Over 37% of adults and 65.3% of children received influenza vaccines at physician offices during the 2016-17 flu season, up from 33% and 63.7% the previous year, respectively, according to the Centers for Disease Control and Prevention. Outside of this setting, adults typically received their flu shot at their workplace or at drug stores, while children received their vaccine at clinics or schools.
This is just some of the information contained in HIDA’s recently-released Influenza Vaccine Production & Distribution Market Brief. Other useful insights in this year’s report include:
Manufacturers’ predictions for vaccine production. By March 3, 2017, manufacturers shipped 145.9 million doses of the flu vaccine. By March of next year, they plan to have shipped a substantial increase to the 2017 number.
HHS updates to its pandemic influenza plan. The new plan aims to “modernize medical countermeasure distribution” by drawing on consumer demand data and distributors’ expertise.
CMS adds two new vaccine reporting measures. Under the agency’s Quality Reporting Program, the Centers for Medicare and Medicaid Services requires providers submit data on patients six months or older, and on healthcare workers who work with certain patient populations.
For more information, or to purchase a copy of the report, visit: www.HIDA.org/FluBrief.